Healthcare Holding Schweiz Strengthens Its Market Position with Effectum CH-Rep Acquisition

Strengthening Market Presence: Healthcare Holding Schweiz Acquires Effectum CH-Rep

Healthcare Holding Schweiz AG, a prominent provider of medical devices and services in Switzerland, has recently finalized its acquisition of Effectum CH-Rep AG. This strategic move is designed to enhance its service offerings to manufacturers of medical technology around the world.

Aiming for Comprehensive Service

The acquisition represents a significant shift as it removes Effectum CH-Rep AG from its former role as an Authorized Swiss Representative (CH-REP) for Effectum Medical AG. Under the new regulations set forth in the Medical Devices Ordinance (MedDO SR 812.213), which became effective on May 26, 2021, manufacturers without a registered office in Switzerland must appoint an authorized representative to market their products within the country. By integrating Effectum CH-Rep into its operations, Healthcare Holding Schweiz AG positions itself as a complete solution provider in the field of medical technology, expanding its capabilities to import, distribute, and ensure compliance with regulatory requirements.

Leadership Insights on the Acquisition

Fabio Fagagnini, the CEO of Healthcare Holding Schweiz, expressed his enthusiasm for the acquisition, stating, "With Effectum CH-Rep, we broaden our service portfolio to include the role of Authorized Representative in Switzerland. This allows our sales representatives and directors to focus even more on innovative products and exceptional customer service, ensuring that all regulatory requirements are met professionally."

Kim Züger, the Director of Quality Management and Regulatory Affairs, who has been appointed the new head of Effectum CH-Rep, emphasized the importance of regulatory compliance, saying, "Compliance is our top priority. Through Effectum CH-Rep, we offer this service not only to our own suppliers but also to numerous other manufacturers, clearly demonstrating our professionalism and high standards of quality."

Michael Eggimann, a board member of Effectum Medical AG, noted the longstanding collaboration between their teams, expressing confidence in the new direction: "We have valued our partnership with Fabio Fagagnini and his team for many years and believe that Effectum CH-Rep is in excellent hands. This transition enables us to concentrate fully on developing our legal manufacturing offerings while continuing to closely collaborate with Effectum CH-Rep for the benefit of our customers."

What Effectum CH-Rep Brings to the Table

Effectum CH-Rep AG, headquartered in Olten, plays a crucial role in facilitating access to the Swiss market for foreign medical device manufacturers by acting as their Authorized Representative. The responsibilities include ensuring compliance with Swiss registration requirements, collaborating with Swissmedic on preventive and corrective actions, appointing a Regulatory Compliance Officer (PRRC), providing access to technical documentation, and reporting incidents and complaints.

About Healthcare Holding Schweiz AG

As a leading platform for purchasing, development, and technology, Healthcare Holding Schweiz AG is at the forefront of medical technology in Switzerland. The group aims for ambitious growth strategies through acquisitions, often in contexts of succession agreements, partnerships, and organic growth. Committed to the highest standards of innovation and customer satisfaction, Healthcare Holding Schweiz continuously exploits technology to enhance business processes for improved security and efficiency. As a market leader, the firm sets new industry benchmarks and provides attractive development opportunities for its employees. All members of the management team possess shares in Healthcare Holding Schweiz, fostering a dynamic entrepreneurial community.

Conclusion

This acquisition marks a significant step for Healthcare Holding Schweiz AG, enabling it to better serve the needs of medical technology manufacturers globally. With enhanced service offerings, the company is poised to maintain its leadership status and continue driving innovation in the industry.

For more details on Healthcare Holding Schweiz AG, visit Healthcare Holding's Website.